Colin Chong

Title: Colin Chong - Innovator in Cancer Treatment

Introduction

Colin Chong is a notable inventor based in Fremont, CA, who has made significant contributions to the field of cancer treatment. His innovative work focuses on developing combinations of therapeutic agents that aim to improve patient outcomes in oncology.

Latest Patents

Colin Chong holds a patent for "Combinations for the treatment of cancer." This invention relates to combinations comprising a checkpoint inhibitor and a c-Met inhibitor, specifically Compound 1. The patent also covers crystalline forms of the free base of Compound 1, as well as crystalline forms of its salts, in combination with a checkpoint inhibitor. Furthermore, the invention outlines methods for treating cancer by administering Compound 1 either as a single agent or in combination with other described agents.

Career Highlights

Colin Chong is currently employed at Exelixis, Inc., a company known for its focus on developing innovative cancer therapies. His work at Exelixis has positioned him as a key player in the advancement of cancer treatment options.

Collaborations

Colin has collaborated with esteemed colleagues such as Gisela Schwab and Christian Scheffold, contributing to a dynamic research environment that fosters innovation in cancer therapies.

Conclusion

Colin Chong's contributions to cancer treatment through his patent and work at Exelixis, Inc. highlight his commitment to improving patient care in oncology. His innovative approaches continue to pave the way for advancements in cancer therapies.